603739 蔚藍生物
按盤價 
14.260 -0.030 (-0.210%) | 2025/09 - 九個月 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 3.518 | 3.635 | 4.814 | 4.299 | 10.049 |
| 總資產報酬率 ROA (%) | 2.052 | 2.083 | 2.876 | 2.910 | 7.218 |
| 投入資產回報率 ROIC (%) | 2.532 | 2.582 | 3.481 | 3.455 | 8.896 | 邊際利潤分析 |
| 銷售毛利率 (%) | 44.447 | 45.046 | 46.227 | 43.231 | 46.255 |
| 營業利潤率 (%) | 10.785 | 9.390 | 10.251 | 8.847 | 14.847 |
| 息稅前利潤/營業總收入 (%) | 11.971 | 10.919 | 11.400 | 9.239 | 15.167 |
| 淨利潤/營業總收入 (%) | 8.164 | 6.979 | 8.579 | 7.343 | 13.043 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 63.574 | 80.000 | 85.724 | 86.406 | 78.342 |
| 價值變動淨收益/利潤總額(%) | 25.107 | 5.734 | 12.765 | 3.406 | 4.449 |
| 營業外收支淨額/利潤總額(%) | -1.081 | -0.470 | -0.331 | -0.701 | 0.312 | 償債能力分析 |
| 流動比率 (X) | 1.081 | 1.037 | 1.033 | 1.503 | 2.610 |
| 速動比率 (X) | 0.877 | 0.853 | 0.844 | 1.234 | 2.188 |
| 資產負債率 (%) | 37.492 | 37.269 | 39.837 | 32.764 | 24.133 |
| 帶息債務/全部投入資本 (%) | 25.915 | 24.840 | 27.954 | 22.397 | 10.175 |
| 股東權益/帶息債務 (%) | 276.043 | 291.569 | 249.206 | 336.089 | 848.541 |
| 股東權益/負債合計 (%) | 155.571 | 156.413 | 141.336 | 194.654 | 299.252 |
| 利息保障倍數 (X) | 9.201 | 6.942 | 9.637 | 20.368 | 55.576 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 100.805 | 91.742 | 93.284 | 84.607 | 68.229 |
| 存貨周轉天數 (天) | 97.055 | 97.800 | 105.830 | 90.137 | 81.996 |
| 備註： | 即時報價更新時間為 24/12/2025 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
